
The Control Arc: Semaglutide, Tirzepatide, and the New Appetite Story
Hunger was never just a test of character. Incretin-based medicines changed the conversation by targeting biological signals—and newer research is asking what comes next.
Recomp Report Editorial Team · 12 October 2026





